ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 1872

Nationwide Analysis of Prosthetic Joint Complications with and Without Inflammatory Arthritis

Annika Sengupta1, Faria Sami2 and Shilpa Arora3, 1John H Stroger Hospital of Cook County, Chicago, IL, 2University of Alabama, Chicago, IL, 3Cook County Hospital, Chicago, IL

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Prosthetic Joint

Session Information

Date: Monday, November 18, 2024

Title: Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Prosthetic joint complications (PJC) are a major concern after joint replacement surgeries especially in patients with history of inflammatory arthritis. We aimed to compare PJC hospitalizations among patients with and without inflammatory arthritis (IA).

Methods: We utilized the 2016-2020 National Inpatient Sample (NIS) Database to obtain all PJC hospitalizations. These were divided into two groups of with and without IA (Rheumatoid Arthritis, Spondylarthritis, Psoriatic Arthritis or Inflammatory Bowel Disease related arthritis). The two groups were compared for demographics, length of stay, total charges and outcomes using Chi square and Wilcoxon rank-sum tests. We also compared individual PJC in all adult hospitalizations with and without IA.

Results: We identified a total of 869,519 PJC hospitalizations out of which 54,705 (6.3%) had a concomitant diagnosis of IA. There were several epidemiological differences between the two groups of PJC hospitalizations those with and without IA (Table 1). Those with IA were younger (median, IQR age 68, 61-75 vs 69, 61-78, P value < 0.001), had higher proportion of females (75% vs 57%, P value < 0.001), had a marginally higher proportion of minorities (African-Americans, 9% vs 8%, P value 0.015 , Hispanics, 6% vs 5%, P value < 0.001 and Native Americans, 0.8% vs 0.5%, P value < 0.001) and were more likely to have Medicare insurance (72% vs 68%, P value < 0.001) and less likely to be privately insured (20% vs 21%, P value < 0.001) in comparison to those without IA. Sepsis was more common in the IA group (7% vs 6%, P value < 0.001) with longer length of stay (median, IQR 4, 2-7 vs 4, 2-6, P value < 0.001) and higher total hospital charges (Table 1). Overall unadjusted mortality was lower in the IA group (0.7% vs 1%, P value 0.11) in comparison to the non-IA group. All individual PJC (periprosthetic fracture, infection, osteolysis, broken internal joint prosthesis, dislocation, mechanical loosening, and wear of articular surface) were higher in those with IA than those without concomitant IA (P value < 0.001) (Table 2).

Conclusion: Out of all PJC hospitalizations, 1 in 16 had a concomitant diagnosis of chronic inflammatory arthritis. Those with IA were younger, more often female, and exhibit higher comorbidity burden, which translated to slightly longer hospital stay and higher total charges. IA patients were more susceptible to sepsis as well as all individual prosthetic joint complications in comparison to those without IA.

Supporting image 1

Supporting image 2


Disclosures: A. Sengupta: None; F. Sami: None; S. Arora: None.

To cite this abstract in AMA style:

Sengupta A, Sami F, Arora S. Nationwide Analysis of Prosthetic Joint Complications with and Without Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/nationwide-analysis-of-prosthetic-joint-complications-with-and-without-inflammatory-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nationwide-analysis-of-prosthetic-joint-complications-with-and-without-inflammatory-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology